Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.

ta, got it working, still cant see the bottom bit of video and cant cant scroll up and down, but getting there, just need to get my speakers working, not having much luck.

Things are looking very good and hopefully this is the start of the new beginning at last.

up again.
bprg make a presentation at the madrid show, so could there be an announcement tomorrow?

Solid recovery today with some nice chunky buys.

Lemming brief updates 1 November 2005

Stanelco (SEO) continued the roller coaster ride, lost 0.50p to
15p. A small matter of changing its advisor, be it a lazy one,
KBC Peel Hunt to a more proactive Evolution Group whom
have been pretty much by SEO`s side this past year, hardly
missing an opportunity to update investors with progress.
Although the shares have lost their positive momentum, which
seen them rise to giddy heights of 32p earlier this year, the
shares are news driven, and we expect them to put in a new
burst of energy once the BPRG debacle is resolved......even
though we expect BPRG to be the winner. Nevertheless, SEO
have strong IP in GREENSEAL and Starpol 2000, which already
has EU approval, with expected US FDA full approval
imminent.

Prestigious Casino operator London Clubs International (LCI)
looks to be back in favour with speculative punters again. The
shares closed 6p higher, at 127.50p, but off their 52 week high
of 145p, nevertheless, they remain in the money from our 55p
inauguration back in 2003. The shares have woken from their
slumber in recent trading days on the back of renewed
speculation the Malaysian based Genting, is looking to have
another roll of the dice. Genting already has 29.8%, close to a
being forced to show their hand, thus ,make a formal bid. This
could force another predator to show their hand. That is
speculation on our part.

CSR`s positive momentum came to a halt today, even
though the shares had a debut buy note and 840p target
from UBS. This, as you would expect, helped push CSR 45p
yesterday, to 719p. The Swiss broker agrees with what we
have been telling you, that the Bluetooth market, where the
semiconductor maker has a dominant market share, is still in
its infancy. However, the share closed 6.50p lower on profit
taking, at 713p, recording a 332p gain since inauguration in
July 2004.

Doing nicely this morning - Glad I did not sell at 32 - Thanks for the tip Sham

Baza

BioProgress PLC
02 November 2005


BioProgress plc
('BioProgress' or the 'Company')

Grant of Executive and Employee Options

The Board of BioProgress plc (AIM: BPRG; NASDAQ: BPRG), adopted two new share
option schemes on 1 November 2005, the BioProgress plc Employee Share Option
Scheme (the 'Employee Option Scheme') and the Executive Share Option Scheme 2005
(the 'Executive Option Scheme'), and on the same day granted options to
subscribe for 11,000,000 Ordinary Shares of 0.01 pence each in the Company as
set out below to the following directors in respect of the Executive Option
Scheme.

The Executive Option Scheme comprises certain options (totalling 3,500,000
options) exercisable subject to performance criteria which will require the
Company's share price to be no less than 87.3 pence in respect of three out of
five consecutive days following the date of grant ('Performance Options'); and
certain other options (totalling 7,500,000 options) exercisable in two tranches,
an initial 50% with effect from 31 March 2006 and the remaining 50% with effect
from 30 September 2006 ('Non-Performance Options'). The Non-Performance Options
reflect the retirement of an equity issuance scheme which was not taken up by
the directors.

These options were granted at an exercise price of 29.1 pence per share.


Name No. of Performance Options No. of Non-performance Options

Dan Farrow 1,500,000 3,500,000

Richard Trevillion 2,000,000 4,000,000


Mr Farrow now holds a total of 5,000,000 options in the Company. Mr Trevillion
now holds a total of 6,000,000 options in the Company.

The Company will also be making shares available for the grant of options to its
key employees; the Employee Share Option Scheme. These options will be awarded
on an individual achievement basis throughout the Company and used to
incentivise and retain individuals who have and will contribute to the success
of the business going forward.

2 November 2005

For further details please contact:

BioProgress plc 01354 655674
Richard Trevillion, Chief Executive Officer
www.bioprogress.com

These sure are flying today - now up 15%

Any reason whyin particular ?

baza

Baza,

What a great call!! If they drop a bit tomorrow, I might take a punt!

Now 20%!

Probably the incentive to get the share to 87p.

The shares were well undervalued and due a re rating, with the videos of the working Nrobe coupled with the FMC execs talking about how good it was and the options sorted out the doubt has been taken away from the share.

It now appears the Biotec factory is working 24/7 to fulfill the Colgate contract for Max Fresh, this alone is enough to take the whole company into profit. Add in our core technologies and it's easy to see why this should be valued at well north of 100 million, it's one of those shares that you'll only stumble upon once in your life; a true British giant in the making with the technology to change how we all take our medicines.

I honestly believe this is one to buy and hold, the upside is huge, the downside very limited.

DYOR you'll soon feel how I do about this major in the making.

Must say the chart looks healthier .

you change your tune just cos of 1 days share price upwards dil!!!!!!!!!!!

lol, what a plonker

Bugz - a bit of luck and opportunism - will be an interesting few days as these could now start to break back as they appear to have sorted a few things out. On the other hand it could be a flash in the pan and they might retrench today - but somehow I dont think so.

Good Luck

New broker is great news, cscs were a millstone around our necks who didn't even do a broker note for us in all that time; new broker is primary based in the US, suggests to me thats where we'll be doing most of our business.

The videos that fmc tried to stop us from seeing-Thanks to hughest and shanksy from adv thread

http://media.putfile.com/FMC---Montage

http://media.putfile.com/FMC---SciCred

http://media.putfile.com/FMC---Rejuvenation

http://media.putfile.com/FMC---Transparency

so what is so exciting about these videos - why are they so important??

I am no longer a holder in BPRG - but was until last Friday when I took profits. Have I sold too early ?

Baza

Baza
On the page that these originally came from (although has now be stopped) was a line saying that Magenta would commercialize in q1 2006.
The videos talk about rejuvinating fmc etc. The essence is that the page was not intended for public viewing.

Sunday Times. 'Colgate in alliance to fight oral cancer'. 06 Nov 2005
Colgate is investing millions of dollars to develop toothpastes and mouthwashes that could protect customers against oral cancer


http://www.timesonline.co.uk/article/0,,2095-1859140,00.html

BPRG would surely be part of this